 JERUSALEM, Feb. 15, 2022 PRNewswire -- BiondVax Pharmaceuticals Ltd. Nasdaq: BVXV, a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses, today announced that CEO Amir Reichman is presenting at the BIO CEO Investor Conference being held this week. 